Literature DB >> 24870597

MicroRNA-520a-5p displays a therapeutic effect upon chronic myelogenous leukemia cells by targeting STAT3 and enhances the anticarcinogenic role of capsaicin.

Burçin Tezcanlı Kaymaz1, Vildan Bozok Cetintaş, Cağdaş Aktan, Buket Kosova.   

Abstract

Aberrant expression profiles of microRNAs (miRNAs) have been previously demonstrated for having essential roles in a wide range of cancer types including leukemia. Antiproliferative or proapoptotic effects of capsaicin have been reported in several cancers. We aimed to study miRNAs involved in the Janus kinase/signal transducers and activators of transcription (JAK/STAT) pathway in chronic myeloid leukemia cell model and the effects of the capsaicin treatment on cell proliferation and miRNA regulation. miR-520a-5p expression was extremely downregulated in capsaicin-treated cells. Repressing the level of miR-520a-5p by transient transfection with specific miRNA inhibitor oligonucleotides resulted in induced inhibition of proliferation in leukemic cells. According to bioinformatics analysis, STAT3 messenger RNA was predicted as a putative miR-520a-5p target; which was confirmed by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and Western blot analysis. Cell proliferation inhibition was enhanced upon knockdown of STAT3 by RNA interference applications, but when miR-520a-5p inhibitor was additionally transfected onto STAT3 silenced cells, cell viability was dramatically decreased in leukemia cells. Finally, we observed the effects of capsaicin following miR-520a-5p inhibitor transfection upon cell proliferation, apoptosis, and STAT3 expression levels. We determined that, downregulation of miR-520a-5p affected the proliferation inhibition enhanced by capsaicin and reduced STAT3 mRNA and protein expression levels and increased apoptotic cell number. In summary, miR-520a-5p displays a therapeutic effect by targeting STAT3 and impacting the anticancer effects of capsaicin; whereas capsaicin, potentially through the miR-520a-5p/STAT3 interaction, induces apoptosis and inhibits K562 leukemic cell proliferation with need of further investigation.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24870597     DOI: 10.1007/s13277-014-2138-z

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  41 in total

Review 1.  New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance.

Authors:  Hagop M Kantarjian; Moshe Talpaz; Francis Giles; Susan O'Brien; Jorge Cortes
Journal:  Ann Intern Med       Date:  2006-12-19       Impact factor: 25.391

Review 2.  Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).

Authors:  Alessandro Allegra; Andrea Alonci; Salvatore Campo; Giuseppa Penna; Annamaria Petrungaro; Demetrio Gerace; Caterina Musolino
Journal:  Int J Oncol       Date:  2012-10-01       Impact factor: 5.650

3.  Selective induction of apoptosis by capsaicin in transformed cells: the role of reactive oxygen species and calcium.

Authors:  A Macho; M A Calzado; J Muñoz-Blanco; C Gómez-Díaz; C Gajate; F Mollinedo; P Navas; E Muñoz
Journal:  Cell Death Differ       Date:  1999-02       Impact factor: 15.828

4.  Growth inhibition of capsaicin on HeLa cells is not mediated by intracellular calcium mobilization.

Authors:  K Takahata; X Chen; K Monobe; M Tada
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

5.  Involvement of Bax, Bcl-2, Ca2+ and caspase-3 in capsaicin-induced apoptosis of human leukemia HL-60 cells.

Authors:  Mei-Fen Tsou; Hsu-Feng Lu; Ssu-Ching Chen; Lii-Tzu Wu; Yi-Shuan Chen; Hsiu-Maan Kuo; Song-Shei Lin; Jing-Gung Chung
Journal:  Anticancer Res       Date:  2006 May-Jun       Impact factor: 2.480

6.  Capsaicin attenuates palmitate-induced expression of macrophage inflammatory protein 1 and interleukin 8 by increasing palmitate oxidation and reducing c-Jun activation in THP-1 (human acute monocytic leukemia cell) cells.

Authors:  Sung-E Choi; Tae Ho Kim; Sang-A Yi; Yun Cheong Hwang; Won Sun Hwang; Sun Jung Choe; Seung Jin Han; Hae Jin Kim; Dae Jung Kim; Yup Kang; Kwan-Woo Lee
Journal:  Nutr Res       Date:  2011-06-17       Impact factor: 3.315

7.  MicroRNAs associated with tumour migration, invasion and angiogenic properties in A549 and SK-Lu1 human lung adenocarcinoma cells.

Authors:  Chai San Ho; Seow Hui Yap; Neoh Hun Phuah; Lionel L A In; Noor Hasima
Journal:  Lung Cancer       Date:  2013-12-06       Impact factor: 5.705

8.  Induction of apoptosis in human myeloid leukemic cells by 1'-acetoxychavicol acetate through a mitochondrial- and Fas-mediated dual mechanism.

Authors:  Keisuke Ito; Tomonori Nakazato; Akira Murakami; Kenji Yamato; Yoshitaka Miyakawa; Taketo Yamada; Nobumichi Hozumi; Hajime Ohigashi; Yasuo Ikeda; Masahiro Kizaki
Journal:  Clin Cancer Res       Date:  2004-03-15       Impact factor: 12.531

Review 9.  Role of epigenetics in chronic myeloid leukemia.

Authors:  Katerina Machova Polakova; Jitka Koblihova; Tomas Stopka
Journal:  Curr Hematol Malig Rep       Date:  2013-03       Impact factor: 3.952

10.  miRNA signature associated with outcome of gastric cancer patients following chemotherapy.

Authors:  Chang Hee Kim; Hark K Kim; R Luke Rettig; Joseph Kim; Eunbyul T Lee; Olga Aprelikova; Il J Choi; David J Munroe; Jeffrey E Green
Journal:  BMC Med Genomics       Date:  2011-11-23       Impact factor: 3.063

View more
  12 in total

1.  Capsaicin enhances the antitumor activity of sorafenib in hepatocellular carcinoma cells and mouse xenograft tumors through increased ERK signaling.

Authors:  Su-Shan Zhang; Yu-Hao Ni; Chen-Ru Zhao; Zhen Qiao; Hong-Xia Yu; Lu-Yao Wang; Jin-Yan Sun; Chen Du; Jia-Hao Zhang; Li-Ying Dong; KeWei Wang; Jian-Jun Gao
Journal:  Acta Pharmacol Sin       Date:  2017-11-30       Impact factor: 6.150

Review 2.  An updated review on molecular mechanisms underlying the anticancer effects of capsaicin.

Authors:  Seok-Cheol Cho; Hyosung Lee; Bu Young Choi
Journal:  Food Sci Biotechnol       Date:  2017-02-28       Impact factor: 2.391

3.  Expression and functions of the STAT3-SCLIP pathway in chronic myeloid leukemia cells.

Authors:  Li Li; Yanlong Zheng; Wanzhuo Xie
Journal:  Exp Ther Med       Date:  2016-10-03       Impact factor: 2.447

4.  The microRNA-520a-3p inhibits invasion and metastasis by targeting NF-kappaB signaling pathway in non-small cell lung cancer.

Authors:  Xiang Fang; Huiying Shi; Fang Sun
Journal:  Clin Transl Oncol       Date:  2022-03-05       Impact factor: 3.340

Review 5.  miRNAs as Biomarkers in Chronic Myelogenous Leukemia.

Authors:  Kasuen Kotagama; Yung Chang; Marco Mangone
Journal:  Drug Dev Res       Date:  2015-08-18       Impact factor: 4.360

6.  Overexpression of miR-574-3p suppresses proliferation and induces apoptosis of chronic myeloid leukemia cells via targeting IL6/JAK/STAT3 pathway.

Authors:  Haoying Yang; Jun Zhang; Jiuping Li; Furong Zhao; Yao Shen; Xuemei Xing
Journal:  Exp Ther Med       Date:  2018-09-05       Impact factor: 2.447

7.  miRNA143 Induces K562 Cell Apoptosis Through Downregulating BCR-ABL.

Authors:  Bing Liang; Yanbin Song; Wenling Zheng; Wenli Ma
Journal:  Med Sci Monit       Date:  2016-08-05

8.  High circ-SEC31A expression predicts unfavorable prognoses in non-small cell lung cancer by regulating the miR-520a-5p/GOT-2 axis.

Authors:  Mingming Jin; Chunzi Shi; Qian Hua; Tian Li; Chen Yang; Yue Wu; Licong Zhao; Hao Yang; Jiaqi Zhang; Cheng Hu; Gang Huang
Journal:  Aging (Albany NY)       Date:  2020-06-04       Impact factor: 5.682

Review 9.  Antiangiogenic Effect of Alkaloids.

Authors:  Masoud Alasvand; Vahideh Assadollahi; Roberto Ambra; Ehsan Hedayati; Wesam Kooti; Ilaria Peluso
Journal:  Oxid Med Cell Longev       Date:  2019-04-21       Impact factor: 6.543

Review 10.  Two Worlds Colliding: The Interplay Between Natural Compounds and Non-Coding Transcripts in Cancer Therapy.

Authors:  Alexandru A Sabo; Maria Dudau; George L Constantin; Tudor C Pop; Christoph-M Geilfus; Alessio Naccarati; Mihnea P Dragomir
Journal:  Front Pharmacol       Date:  2021-07-06       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.